Authors
Loading...
Randomized trial demonstrates improved prediction of cancer cell line sensitivity in pharmacogenomic contexts, indicating potential for precision oncology.
Zainab et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: